Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc1a506cdfa120bc95f2833fd1d23421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0482d918f7924fc2d6910ab49adbede4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c9d6c293885d7ef020d249c689a3c3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5e73495e43302ba9f5f5270549165c7 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-113 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
filingDate |
2011-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9c6a375d6fbf595c6fd70cb91bc6d0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a154ad957deacefcc5623cb4eb0db9a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f02ca85c96b9937916d0d27fe6251ccd |
publicationDate |
2011-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2011121120-A1 |
titleOfInvention |
ANTAGONISTS OF miRNA-29 EXPRESSION AND THEIR USE IN THE PREVENTION AND TREATMENT OF AORTIC ANEURYSMS |
abstract |
The present invention relates to antagonists of the expression and/or the function of the micro RNA miRNA-29 for use in the prevention and/or treatment of aortic aneurysms. Further disclosed is a method for the identification of miRNA-29 antagonists, a pharmaceutical composition comprising said miRNA-29 antagonists and a method for preventing and treating age-related aortic aneurysm formation in a subject in need of such a treatment. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11351200-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8846396-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9845457-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11220687-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11357799-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11759482-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11660317-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11660355-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9249392-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015518475-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253551-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884076-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9828603-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11541078-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10457942-B2 |
priorityDate |
2010-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |